Dystonia and the Nuclear Envelope
Mutations in torsinA cause dominantly inherited earlyonset torsion dystonia in humans. In this issue of Neuron, Goodchild et al. show that torsinA knockout and knockin mice have similar phenotypes, which suggests that the mutant torsinA allele causes disease because it has decreased function. The experiments also highlight the possible role of nuclear envelope dynamics in maintaining normal neuronal function.
Many neurological diseases have variants that are caused by gene defects. The relationships between Mendelian forms of disease and their sporadic counterparts can be debated, but there is a chance of understanding the basic pathways leading to neuronal dysfunction. However, the usefulness of this information is predicated on understanding how the mutation ''works'' in a genetic sense. For example, a recessive mutation is usually associated with loss of function, which could be tested experimentally if one has an assay for the protein activity. Dominant mutations may work in any number of ways, by increasing the activity of the protein, introducing a new toxic property to the protein such as protein misfolding (gain of novel function), or acting to reduce the activity of the endogenous protein (dominant negative). These distinctions are critical for designing the right experiment to test hypotheses about how diseases are caused and misapplication really causes problems in interpretation. Such information may also change how we design therapeutic strategies and hence is of significant interest.
The genetics of the human dystonias are complicated as there are at least 15 extant loci with different phenotypic presentations (Klein, 2005) . The first identified gene was named torsinA by Ozelius and colleagues and is associated with early-onset torsion dystonia (Ozelius et al., 1997) . All torsinA-related dystonia cases found so far are due to the deletion of one of a pair of glutamate residues (E302/303) toward the C terminus of the encoded protein. TorsinA is part of the large AAA+ family of ATPases and the glutamate deletion is near to the ATP binding region. An interesting aspect of the genetics of torsinA dystonia is that there is greatly reduced penetrance. About one third of patients who carry the causal DE302/303 mutation go on to develop disease, the rest remaining asyptomatic. It is also worth noting that the there appears to be a time-dependent window for susceptibility. Generally, mutation carriers who are asymptomatic in their early 20s remain so throughout life, although there may be exceptions (Bressman et al., 2000) . This implies that there is a critical timing for the expression of symptoms, also implying that dystonia is a developmental disease.
The interpretation of this human genetic evidence is not simple because there are multiple reasonable explanations for both the low penetrance dominant disease and the developmental effects. The study by Goodchild et al. is important because it addresses this problem in a careful but direct manner. The question posed by the experiments is: how closely does the DE302/303 mutation resemble a loss of function allele? The authors address this by comparing the phenotypes of mice with a knockout of torsinA or a knockin mutation in which one of the pair of glutamate residues is removed. If the two mice are similar in phenotype, this would argue quite strongly and in a relevant in vivo context, that the mutation causes a loss of function.
Homozygous knockout mice are born but die shortly thereafter because of a failure to feed. The same is true of homozygous knockin mice with two copies of the DE302/303 allele. Therefore, torsinA is indispensable for one or more developmental processes, and the mutant allele behaves as a null mutation. Critically, mice with a single DE302/303 allele on a knockout background have the same phenotype, showing that the mutant protein fails to act where the wild-type protein would be sufficient to rescue the perinatal lethality.
Furthermore, the homozygous knockout and knockin mice have a morphological phenotype, with small balloon-like extrusions of the nuclear. The deficit is seen in several CNS regions but only in neurons, not in glia or in nonneural tissues. Several previous studies have implicated the nuclear envelope, a specialized subcompartment of the endoplasmic reticulum, as being important in the pathological effects of torsinA. TorsinA mutants selectively accumulate here (Bragg et al., 2004; GonzalezAlegre and Paulson, 2004; Goodchild and Dauer, 2004; Naismith et al., 2004) , and there are two possible protein interaction partners for torsinA in this subcellular compartment .
Therefore, the homozygous knockout and knockin mice have similar phenotypes for both neonatal viability and cellular morphology. Although these experiments clearly suggest that mutant torsinA has decreased function, they do not specifically address whether mutant torsinA has a dominant-negative effect on the function of endogenous protein. Such an effect is feasible if, as previously suggested (Breakefield et al., 2001) , torsinA functions as part of an oligomer whose net activity is decreased by the incorporation of inactive monomers. The current study also shows that net protein levels for torsinA are lower in the knockin mice than in wild-types. This suggests that part of the effect of the torsinA mutation might be to decrease the stability of the monomeric protein. Whether this also affects wild-type proteins in the same complex is not addressed but is possible. Because homozygous DE302/303 mice with the observed phenotypes have more protein than heterozygous knockout mice without the phenotypes, this confirms that not all of the effect is due to protein levels and that the DE302/303 mutant must have intrinsically lower activity than wild-type torsinA.
Such considerations might have implications for sporadic dystonia. Recent work (Clarimon et al., 2005) has shown an association between a G deletion at the 3 0 untranslated region of the gene encoding torsinA and the risk of suffering from idiopathic dystonia in a series from Iceland. Because the average age at onset of patients harboring the G deletion is 36 years old in the Icelandic series, the present results indicate that some cases of primary dystonia including late onset dystonia might be caused by dominantly acting, but less disruptive, mutations in the gene. Because regulatory motifs are frequent at 3 0 UTRs, it is possible that this polymorphism might lead to lower mRNA and protein levels.
Of course, there are many questions that now need to be addressed following this work. The most obvious is to ask why neurons have this specific requirement for torsinA. Goodchild et al. suggest that the phenotype is seen in postmigratory (and presumably postmitotic) neurons, potentially linking torsinA to the disassembly of the nucleokinesis apparatus after neuronal migration. In favor of this hypothesis, at least one torsinA homolog (ooc-5 from C. elegans) participates in the rotation of nuclei during early embryonic development. However, the relationship between the nuclear envelope and the cellular and systems effects of mutations in humans is obscure. Dystonia is not generally a degenerative disease and therefore is thought to derive from an altered function of neurons, likely those in circuits in the basal ganglia important for voluntary movements. One would therefore imagine that the neurons in dystonia patients are present in normal numbers, but are over or under active. A priori, the most obvious place to look at this type of behavior would be out at the synapses. Very speculatively, perhaps dystonia is a disease of altered nuclearsynpatic communication that manifests itself after important developmental decisions in neurons after they have completed cell migration. For example, there are several nuclear envelope proteins that link to the cytoskeleton (Gruenbaum et al., 2005) , which is also critical in anchoring synaptic components in neurons.
Really understanding why torsinA has such an important role in postmigratory neuronal development or function will only be possible once we understand the molecular mechanism(s) involved in its action. It is assumed that the ATPase activity of torsin is important in controlling protein substrates because many AAA+ proteins are critical for the disassembly of multiprotein complexes or unfold single substrates. But what the critical substrates are and, again, why neurons are so reliant on these is not yet known. The torsinA knockout mice may be very valuable in testing possible substrates for their contribution to the torsinA phenotype.
It should also be noted that the homozygous mice have a severe phenotype, whereas heterozygous mice (which have the same genetic lesion as patients with torsinA dystonia) do not exhibit these phenotypes. Perhaps in the heterozygote state, there are more subtle disturbances that manifest in altered neuronal activity with limited changes in the nuclear envelope. Very recently, heterozygous knockin mice for the same allele have been reported that have subtle behavioral changes (Dang et al., 2005) . It will be critical to compare the behaviors of the two lines of heterozygous knockin mice (Dang et al., 2005; with the heterozygous knockout mice as they age. If similar behavioral and neurochemical abnormalities present themselves in the heterozygous knockout state, then this would argue that mutant torsinA is a relatively simple loss-of-function mutation and that although 50% activity is sufficient to support many cells, neuronal function is compromised under the same conditions. In contrast, if the phenotypes can be separated from each other, especially if the heterozygous knockout mice have no phenotype, this might argue that mutant torsinA has a dominantnegative effect. Given that the tools are now available, this would be a critical way to describe how mutations work and to begin to understand how torsinA causes disease.
